Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04655092	Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients	recruiting	Phase 3	67	PharmaEssentia Japan K.K.INDUSTRY	1	Nov 8, 2024	clinicaltrials
NCT06418776	IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML	recruiting	Phase 3	198	National Research Center for Hematology, RussiaNETWORK	1	May 17, 2024	clinicaltrials